Protagenic Therapeutics Files 8-K on Security Holder Vote Matters
Ticker: PTIXW · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-action
Related Tickers: PTIX
TL;DR
PTIX is having a shareholder vote on Feb 21st - expect news soon.
AI Summary
On February 21, 2025, Protagenic Therapeutics, Inc. filed an 8-K report detailing a submission of matters to a vote of its security holders. The company, incorporated in Delaware, is involved in the pharmaceutical preparations industry.
Why It Matters
This filing indicates that Protagenic Therapeutics is seeking approval from its shareholders on certain corporate actions, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not an event that inherently increases risk.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- February 21, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of incorporation
- 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific matters are being submitted for a vote by Protagenic Therapeutics' security holders?
The filing states that matters are being submitted to a vote of security holders, but the specific details of these matters are not provided in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on February 21, 2025.
What is Protagenic Therapeutics, Inc.'s Standard Industrial Classification (SIC) code?
Protagenic Therapeutics, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
In which state was Protagenic Therapeutics, Inc. incorporated?
Protagenic Therapeutics, Inc. was incorporated in Delaware.
What is the Commission File Number for Protagenic Therapeutics, Inc.?
The Commission File Number for Protagenic Therapeutics, Inc. is 001-12555.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding Protagenic Therapeutics, Inc.\new (PTIXW).